Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Di Domenico, Fabio ^a   Foppoli, Cesira ^b   Blarzino, Carla ^a   Perluigi, Marzia ^a   Paolini, Francesca ^c   Morici, Salvatrice ^a   Coccia, Raffaella ^a   Cini, Chiara ^a   De Marco, Federico ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; ONCOPROTEIN; PROTON PUMP; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E5; 3,4 DIHYDROXYBENZYLAMINE; 3,4-DIHYDROXYBENZYLAMINE; ANTINEOPLASTIC ANTIMETABOLITE; BUTHIONINE SULFOXIMINE; DOPAMINE; DRUG DERIVATIVE; MELANIN; ONCOGENE PROTEIN E5, HUMAN PAPILLOMAVIRUS TYPE 16; PROTON PUMP INHIBITOR;

ALKALINIZATION; AMELANOTIC MELANOMA; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL METABOLISM; CELL PH; CELL VACUOLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REACTIVATION; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MELANOGENESIS; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; BIOSYNTHESIS; ENDOSOME; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; PH; SKIN TUMOR; TUMOR CELL LINE; VIROLOGY;

ANTIMETABOLITES, ANTINEOPLASTIC; BUTHIONINE SULFOXIMINE; CELL LINE, TUMOR; DOPAMINE; ENDOSOMES; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; MELANINS; MELANOMA, AMELANOTIC; MONOPHENOL MONOOXYGENASE; ONCOGENE PROTEINS, VIRAL; PROTON PUMP INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFECTION;

EID: 62149129576     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-4     Document Type: Article

References (49)

1. Papillomavirus infections-a major cause of human cancers. H zur Hausen, Biochim Biophys Acta 1996 1288 F55 78 8876633
2. Papillomaviruses and cancer: from basic studies to clinical application. H zur Hausen, Nat Rev Cancer 2002 2 342 50 10.1038/nrc798 12044010
3. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. K Munger WC Phelps V Bubb PM Howley R Schlegel, J Virol 1989 63 4417 21 2476573
4. The Role of HPV E6 Oncoprotein in Malignant Progression. M Thomas D Pim L Banks, Papillomavirus Research - From natural history to Vaccines and Beyond Norfolk: Caister Academic Press, Campo MS, 2006 115 132
5. The Biology of the E7 Protein of HPV16. DJ McCance, Papillomavirus Research - From natural history to Vaccines and Beyond Norfolk: Caister Academic Press, Campo MS, 2006 133 144
6. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. C Leptak S Ramon y Cajal R Kulke BH Horwitz DJ Riese 2nd GP Dotto D DiMaio, J Virol 1991 65 7078 83 1658398
7. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. V Bouvard G Matlashewski ZM Gu A Storey L Banks, Virology 1994 203 73 80 10.1006/viro.1994.1456 8030286
8. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. GF Valle L Banks, J Gen Virol 1995 76 1239 45 10.1099/0022-1317-76-5-1239 7730808
9. Mucosal Human Papillomaviruses Encode Four Different E5 Proteins Whose Chemistry and Phylogeny Correlate with Malignant or Benign Growth. IG Bravo A Alonso, J Virology 2004 78 13613 13626 15564472 10.1128/JVI.78.24.13613-13626. 2004
10. The carcinogenicity of human papillomavirus types reflects viral evolution. M Schiffman R Herrero R Desalle A Hildesheim S Wacholder AC Rodriguez MC Bratti ME Sherman J Morales D Guillen M Alfaro M Hutchinson TC Wright D Solomon Z Chen J Schussler PE Castle RD Burk, Virology 2005 337 76 84 10.1016/j.virol.2005.04.002 15914222
11. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. M Conrad VJ Bubb R Schlegel, J Virol 1993 67 6170 8 7690419
12. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. K Crusius E Auvinen B Steuer H Gaissert A Alonso, Exp Cell Res 1998 241 76 83 10.1006/excr.1998.4024 9633515
13. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. Z Gu G Matlashewski, J Virol 1995 69 8051 6 7494320
14. Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells. SL Chen P Mounts, J Virol 1990 64 3226 33 2161939
15. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. GH Ashrafi MR Haghshenas B Marchetti PM O'Brien MS Campo, Int J Cancer 2005 113 276 83 10.1002/ijc.20558 15386416
16. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. B Zhang P Li E Wang Z Brahmi KW Dunn JS Blum A Roman, Virology 2003 310 100 8 10.1016/S0042-6822(03)00103-X 12788634
17. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? FA Suprynowicz GL Disbrow V Simic R Schlegel, Virology 2005 332 102 13 10.1016/j.virol.2004.11.011 15661144
18. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. MI Rodriguez ME Finbow A Alonso, Oncogene 2000 19 3727 32 10.1038/sj.onc.1203718 10949926
19. Composition and assembly of the yeast vacuolar H(+)-ATPase complex. LA Graham B Powell TH Stevens, J Exp Biol 2000 203 61 70 10600674
20. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. SW Straight PM Hinkle RJ Jewers DJ McCance, J Virol 1993 67 4521 32 8392596
21. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. SW Straight B Herman DJ McCance, J Virol 1995 69 3185 92 7707548
22. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. JL Adam MW Briggs DJ McCance, Virology 2000 272 315 25 10.1006/viro.2000.0376 10873774
23. The HPV16 E5 oncogene inhibits endocytic trafficking. P Thomsen B van Deurs B Norrild L Kayser, Oncogene 2000 19 6023 32 10.1038/sj.onc.1204010 11146554
24. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. J Ancans DJ Tobin MJ Hoogduijn NP Smit K Wakamatsu AJ Thody, Exp Cell Res 2001 268 26 35 10.1006/excr.2001.5251 11461115
25. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. BB Fuller DT Spaulding DR Smith, Exp Cell Res 2001 262 197 208 10.1006/excr.2000.5092 11139343
26. Activation of melanogenesis by vacuolar type H(+)-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. J Ancans AJ Thody, FEBS Lett 2000 478 57 60 10.1016/S0014-5793(00)01795-6 10922469
27. Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. F De Marco M Perluigi ML Marcante R Coccia C Foppoli C Blarzino MA Rosei, Biochem Pharmacol 2002 64 1503 12 10.1016/S0006-2952(02)01353-9 12417263
28. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. EJ Bowman A Siebers K Altendorf, Proc Natl Acad Sci USA 1988 85 7972 6 2973058 10.1073/pnas.85.21.7972
29. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases. S Drose KU Bindseil EJ Bowman A Siebers A Zeeck K Altendorf, Biochemistry 1993 32 3902 6 10.1021/bi00066a008 8385991
30. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. GH Ashrafi E Tsirimonakis B Marchetti P O'Brien GJ Sibbet L Andrew MS Campo, Oncogene 2002 21 248 259 10.1038/sj.onc.1205008 11803468
31. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. R Mann RC Mulligan D Baltimore, Cell 1983 33 153 9 10.1016/0092-8674(83)90344-6 6678608
32. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. A Calogero H Timmer-Bosscha H Schraffordt Koops AT Tiebosch NH Mulder GA Hospers, Br J Cancer 2000 83 184 7 10.1054/bjoc.2000.1282 10901368
33. Use of MTT colorimetric assay to measure cell activation. D Gerlier N Thomasset, J Immunol Methods 1986 94 57 63 10.1016/0022-1759(86)90215-2 3782817
34. Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus sequences. F De Marco A Di Lonardo A Venuti ML Marcante, J Biol Regul Homeost Agents 1991 5 65 70 1716817
35. Acridine orange as a probe for measuring pH gradients across membranes: mechanism and limitations. MG Palmgren, Anal Biochem 1991 192 316 21 10.1016/0003-2697(91)90542-2 1827963
36. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1. C Foppoli F De Marco C Blarzino M Perluigi C Cini R Coccia, Int J Biochem Cell Biol 2005 37 852 63 10.1016/j.biocel.2004.11.002 15694844
37. Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. K Iozumi GE Hoganson R Pennella MA Everett BB Fuller, J Invest Dermatol 1993 100 806 11 10.1111/1523-1747.ep12476630 8496620
38. Pigmentation in melanomas: Changes manifesting underlying oncogenic and metabolic activities. R Halaban, Oncol Res 2002 13 3 8 12201672
39. Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT. W Zhang R Tsan DH Nam W Lu IJ Fidler, Neoplasia 2006 8 543 50 16867216 10.1593/neo.05655
40. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. JA Prezioso GB Fitzgerald MM Wick, Pigment Cell Res 1990 3 49 54 10.1111/j.1600-0749.1990.tb00322.x 2117268
41. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases. SJ Orlow WK Silvers BK Zhou B Mintz, Cancer Res 1998 58 1521 3 9537258
42. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. H Takeuchi C Kuo DL Morton HJ Wang DS Hoon, Cancer Res 2003 63 441 8 12543800
43. Mechanisms of cell transformation by papillomavirus E5 proteins. D DiMaio D Mattoon, Oncogene 2001 20 7866 73 10.1038/sj.onc.1204915 11753669
44. E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. AD Ashby L Meagher MS Campo ME Finbow, J Gen Virol 2001 82 2353 62 11562529
45. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. IG Bravo K Crusius A Alonso, Arch Virol 2005 150 231 46 10.1007/s00705-004-0420-x 15503216
46. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. FA Suprynowicz GL Disbrow E Krawczyk V Simic K Lantzky R Schlegel, Oncogene 2008 27 1071 1078 10.1038/sj.onc.1210725 17704805
47. Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. N Kivi D Greco P Auvinen E Auvinen, Oncogene 2008 27 2532 41 10.1038/sj.onc.1210916 17982485
48. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. H Watabe JC Valencia K Yasumoto T Kushimoto H Ando J Muller WD Vieira M Mizoguchi E Appella VJ Hearing, J Biol Chem 2004 279 7971 81 10.1074/jbc.M309714200 14634018
49. The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth. C Lewis MF Baro M Marques M Grüner A Alonso IG Bravo, Virol J 2008 5 30 18302753 10.1186/1743-422X-5-30